Globus Medical (NYSE:GMED) reported its Q4 earnings results on Tuesday, February 20, 2024 at 04:15 PM.
Here’s what investors need to know about the announcement.
Earnings
Globus Medical missed estimated earnings by 1.64%, reporting an EPS of $0.6 versus an estimate of $0.61.
Revenue was up $342.04 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 0.69% drop in the share price the next day.
Here’s a look at Globus Medical’s past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.54 | 0.59 | 0.51 | 0.56 |
| EPS Actual | 0.57 | 0.63 | 0.53 | 0.59 |
| Revenue Estimate | 268.78M | 279.72M | 254.90M | 276.67M |
| Revenue Actual | 383.64M | 291.62M | 276.69M | 274.50M |
To track all earnings releases for Globus Medical visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
